Keywords: Celgene, Sutra Biopharma, ispecific antibodies, Amgen, US Court settlement, Aranesp, Misbranding

News briefs: Celgene deal with Sutro; Amgen pleads guilty to misbranding

Article | 19 December 2012

Print This

US biotech firm Celgene Corp (Nasdaq: CELG) has entered a collaboration with San Francisco-based Sutra Biopharma to design and develop ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in